Alejandro Olivares-Hernández

8PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 30, 2026
Exploratory plasma ctDNA genomic biomarkers identified by whole-exome sequencing and a novel bioinformatics pipeline in advanced driver-negative NSCLC.

|Mar 28, 2026
A Complete Response to Immunotherapy in a Patient with Locally Advanced Squamous Cell Lung Cancer Harboring a Novel TMEM178B::BRAF Fusion: A Case Report.

Juan Carlos Redondo-González, Iñigo San Miguel, Marta Rodríguez-González

|Dec 05, 2025
A comprehensive review of sex differences in the clinical outcomes to immunotherapy on solid tumors.

Juan Carlos Redondo-González, Luis Posado-Domínguez, Laura Corvo-Félix

|Nov 07, 2024
Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50.

Alejandro Olivares-Hernández, Luis Posado-Domínguez, Juan Carlos Redondo-González

|Jul 27, 2024
Cancer-Associated Thrombotic Microangiopathy: Literature Review and Report of Five Cases.

L Posado-Domínguez, A-J Chamorro, E Del Barco-Morillo

|Feb 24, 2024
Differentially Expressed Genes Involved in Primary Resistance to Immunotherapy in Patients with Advanced-Stage Pulmonary Cancer.

Luis Miguel Chinchilla-Tábora, Juan Carlos Montero, Luis Antonio Corchete

Pageof 2

Frequent Collaborators

3 joint publications

Luis Posado-Domínguez

2 joint publications

Juan Carlos Redondo-González

2 joint publications

Edel Del Barco-Morillo

2 joint publications

Luis Figuero-Pérez